Clinical Trial Update: Efficacy/Safety of HCP1306 Tablet Versus HGP0816 Tablet in Patients With Primary Hypercholesterolemia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing HCP1306 versus HGP0816 tablets in patients with primary hypercholesterolemia has completed. The update provides information on the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• HCP1306 Tablet
• HGP0816 Tablet

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Primary Hypercholesterolemia | Phase 3 | Status: COMPLETED